Review



naïve cd8 t cell isolation kit  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Miltenyi Biotec naïve cd8 t cell isolation kit
    GPCR68 as a pH-Sensing regulator in T Cells and generation of GPCR68 fl/fl CD4 Cre mice. (A) Schematic diagram of the effect of pH on T cell GPCR68 as well as tumor. (B) Naïve CD4 + T cells were isolated and activated using anti-CD3 and anti-CD28 using the culture media with varying pH. RT-qPCR was performed to determine the expression of GPCR68 at various pH. (C) Naïve CD4 + T cells were activated with anti-CD3 and anti-CD28 under different pH conditions, and GPCR68 protein expression was assessed by Western blot analysis. (D) To generate conditional knockout (CKO) of GPCR68 in T cells, GPCR68 fl/fl mice were crossed with CD4 Cre mice and generated GPCR68 fl/fl CD4 Cre (CKO). (E) Flow cytometry was used to determine the population of CD4 and <t>CD8</t> cells in the lymph nodes (LN), thymus (THY), and spleen (SP) at the basal level in CD4 Cre or GPCR68 fl/fl CD4 Cre mice. (F) Flow cytometry was used to determine the population of Foxp3+ Treg cells in the lymph nodes, thymus, and spleen at the basal level in the CD4 Cre or GPCR68 fl/fl CD4 Cre mice. (G-H) The population of F4/80+, CD11c+ (G), and B220+ (H) cells was determined in the lymph nodes and spleen at the basal level in the CD4 Cre or GPCR68 fl/fl CD4 Cre mice. (I-J) Flow cytometry was used to evaluate the CD4 + or CD8 + T cells for the determination of intracellular cytokines IFN-γ+ (I), or TNF-α+ (J) from the spleen and lymph nodes at basal level in the CD4 Cre or GPCR68 fl/fl CD4 Cre mice. Student t-test was performed for comparison between the two groups. Data are mean ± SEM (n = 5), ∗ p < 0.05.
    Naïve Cd8 T Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 142 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/Naive+CD8a%2B+T+Cell+Isolation+Kit%2C+mouse/pmc12963920-412-38-46
    Average 96 stars, based on 142 article reviews
    naïve cd8 t cell isolation kit - by Bioz Stars, 2026-11
    96/100 stars

    Images

    1) Product Images from "pH-neutralization strategy to suppress GPCR68 spatiotemporally activates T cells and enhances anti-tumor immunity"

    Article Title: pH-neutralization strategy to suppress GPCR68 spatiotemporally activates T cells and enhances anti-tumor immunity

    Journal: Bioactive Materials

    doi: 10.1016/j.bioactmat.2026.02.039

    GPCR68 as a pH-Sensing regulator in T Cells and generation of GPCR68 fl/fl CD4 Cre mice. (A) Schematic diagram of the effect of pH on T cell GPCR68 as well as tumor. (B) Naïve CD4 + T cells were isolated and activated using anti-CD3 and anti-CD28 using the culture media with varying pH. RT-qPCR was performed to determine the expression of GPCR68 at various pH. (C) Naïve CD4 + T cells were activated with anti-CD3 and anti-CD28 under different pH conditions, and GPCR68 protein expression was assessed by Western blot analysis. (D) To generate conditional knockout (CKO) of GPCR68 in T cells, GPCR68 fl/fl mice were crossed with CD4 Cre mice and generated GPCR68 fl/fl CD4 Cre (CKO). (E) Flow cytometry was used to determine the population of CD4 and CD8 cells in the lymph nodes (LN), thymus (THY), and spleen (SP) at the basal level in CD4 Cre or GPCR68 fl/fl CD4 Cre mice. (F) Flow cytometry was used to determine the population of Foxp3+ Treg cells in the lymph nodes, thymus, and spleen at the basal level in the CD4 Cre or GPCR68 fl/fl CD4 Cre mice. (G-H) The population of F4/80+, CD11c+ (G), and B220+ (H) cells was determined in the lymph nodes and spleen at the basal level in the CD4 Cre or GPCR68 fl/fl CD4 Cre mice. (I-J) Flow cytometry was used to evaluate the CD4 + or CD8 + T cells for the determination of intracellular cytokines IFN-γ+ (I), or TNF-α+ (J) from the spleen and lymph nodes at basal level in the CD4 Cre or GPCR68 fl/fl CD4 Cre mice. Student t-test was performed for comparison between the two groups. Data are mean ± SEM (n = 5), ∗ p < 0.05.
    Figure Legend Snippet: GPCR68 as a pH-Sensing regulator in T Cells and generation of GPCR68 fl/fl CD4 Cre mice. (A) Schematic diagram of the effect of pH on T cell GPCR68 as well as tumor. (B) Naïve CD4 + T cells were isolated and activated using anti-CD3 and anti-CD28 using the culture media with varying pH. RT-qPCR was performed to determine the expression of GPCR68 at various pH. (C) Naïve CD4 + T cells were activated with anti-CD3 and anti-CD28 under different pH conditions, and GPCR68 protein expression was assessed by Western blot analysis. (D) To generate conditional knockout (CKO) of GPCR68 in T cells, GPCR68 fl/fl mice were crossed with CD4 Cre mice and generated GPCR68 fl/fl CD4 Cre (CKO). (E) Flow cytometry was used to determine the population of CD4 and CD8 cells in the lymph nodes (LN), thymus (THY), and spleen (SP) at the basal level in CD4 Cre or GPCR68 fl/fl CD4 Cre mice. (F) Flow cytometry was used to determine the population of Foxp3+ Treg cells in the lymph nodes, thymus, and spleen at the basal level in the CD4 Cre or GPCR68 fl/fl CD4 Cre mice. (G-H) The population of F4/80+, CD11c+ (G), and B220+ (H) cells was determined in the lymph nodes and spleen at the basal level in the CD4 Cre or GPCR68 fl/fl CD4 Cre mice. (I-J) Flow cytometry was used to evaluate the CD4 + or CD8 + T cells for the determination of intracellular cytokines IFN-γ+ (I), or TNF-α+ (J) from the spleen and lymph nodes at basal level in the CD4 Cre or GPCR68 fl/fl CD4 Cre mice. Student t-test was performed for comparison between the two groups. Data are mean ± SEM (n = 5), ∗ p < 0.05.

    Techniques Used: Isolation, Quantitative RT-PCR, Expressing, Western Blot, Knock-Out, Generated, Flow Cytometry, Comparison

    GPCR68 fl/fl CD4 Cre mice exhibit improved anti-tumor mmune responses. (A-C) Naïve CD4 + T cells were isolated from CD4 Cre or GPCR68 fl/fl CD4 Cre mice and activated using anti-CD3 and anti-CD28 using the culture media under physiologic neutral pH (7.4) or varying pH 6.0, 6.5, or 7.8. Flow cytometry plots showing the expression of IFN-γ and IL-2 in CD4 + T cells from CD4 Cre and GPCR68 fl/fl CD4 Cre mice. Each panel represents the frequency of IFN-γ + and IL-2 + cells. (B) Bar graph summarizing the percentage of IFN-γ + CD4 + T cells at each pH level for CD4 Cre and GPCR68 fl/fl CD4 Cre mice. (C) Bar graph showing the percentage of IL-2 + CD4 + T cells at each pH for CD4 Cre and GPCR68 fl/fl CD4 Cre mice. (D) Experimental timeline depicting tumor induction and treatment protocol in CD4 Cre and GPCR68 fl/fl CD4 Cre mice. (E) Tumor growth curves in CD4 Cre and GPCR68 fl/fl CD4 Cre mice. (F) Tumor weight in CD4 Cre versus GPCR68 fl/fl CD4 Cre mice at the time of harvesting on day 21. (G) Representative images of excised tumors at day 21. (H) Flow cytometric analysis of IFN-γ production by tumor-infiltrating CD4 + and CD8 + T cells. (I) Flow cytometric analysis of TNF-α production by tumor-infiltrating CD4 + and CD8 + T cells. Student t-test was performed for comparison between the two groups. Two-way ANOVA was used for multiple comparisons. Data are mean ± SEM (n = 5). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ns = not significant.
    Figure Legend Snippet: GPCR68 fl/fl CD4 Cre mice exhibit improved anti-tumor mmune responses. (A-C) Naïve CD4 + T cells were isolated from CD4 Cre or GPCR68 fl/fl CD4 Cre mice and activated using anti-CD3 and anti-CD28 using the culture media under physiologic neutral pH (7.4) or varying pH 6.0, 6.5, or 7.8. Flow cytometry plots showing the expression of IFN-γ and IL-2 in CD4 + T cells from CD4 Cre and GPCR68 fl/fl CD4 Cre mice. Each panel represents the frequency of IFN-γ + and IL-2 + cells. (B) Bar graph summarizing the percentage of IFN-γ + CD4 + T cells at each pH level for CD4 Cre and GPCR68 fl/fl CD4 Cre mice. (C) Bar graph showing the percentage of IL-2 + CD4 + T cells at each pH for CD4 Cre and GPCR68 fl/fl CD4 Cre mice. (D) Experimental timeline depicting tumor induction and treatment protocol in CD4 Cre and GPCR68 fl/fl CD4 Cre mice. (E) Tumor growth curves in CD4 Cre and GPCR68 fl/fl CD4 Cre mice. (F) Tumor weight in CD4 Cre versus GPCR68 fl/fl CD4 Cre mice at the time of harvesting on day 21. (G) Representative images of excised tumors at day 21. (H) Flow cytometric analysis of IFN-γ production by tumor-infiltrating CD4 + and CD8 + T cells. (I) Flow cytometric analysis of TNF-α production by tumor-infiltrating CD4 + and CD8 + T cells. Student t-test was performed for comparison between the two groups. Two-way ANOVA was used for multiple comparisons. Data are mean ± SEM (n = 5). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ns = not significant.

    Techniques Used: Isolation, Flow Cytometry, Expressing, Comparison

    Anti-tumor effects of borate bioactive glass (BOLT) in B16 tumor. (A) Schematic illustration depicting the induction of B16 melanoma tumors, followed by treatment with BOLT at various time points, and tumor harvesting for subsequent analysis. (B) Tumor growth curves showing tumor volume in Control and BOLT-treated B16 melanoma tumors in mice. (C) Tumor weight at the time of harvesting in the BOLT-treated group compared to the Control. (D) Representative images of excised tumors from Control and BOLT-treated mice. (E) In vivo imaging of tumor-bearing mice in both the Control and BOLT-treated groups. (F) Flow cytometry analysis showing IFN-γ production in CD4 + and CD8 + T cells following BOLT treatment compared to Control. (G) Flow cytometry analysis demonstrated TNF-α production in CD4 + and CD8 + T cells in the BOLT-treated group, with a significant increase observed in CD8 + T cells. Student t-test was performed for comparison between the two groups. Two-way ANOVA was used for multiple comparisons. Data represent the mean ± SEM (n = 5). ∗ p < 0.05, ∗∗ p < 0.01.
    Figure Legend Snippet: Anti-tumor effects of borate bioactive glass (BOLT) in B16 tumor. (A) Schematic illustration depicting the induction of B16 melanoma tumors, followed by treatment with BOLT at various time points, and tumor harvesting for subsequent analysis. (B) Tumor growth curves showing tumor volume in Control and BOLT-treated B16 melanoma tumors in mice. (C) Tumor weight at the time of harvesting in the BOLT-treated group compared to the Control. (D) Representative images of excised tumors from Control and BOLT-treated mice. (E) In vivo imaging of tumor-bearing mice in both the Control and BOLT-treated groups. (F) Flow cytometry analysis showing IFN-γ production in CD4 + and CD8 + T cells following BOLT treatment compared to Control. (G) Flow cytometry analysis demonstrated TNF-α production in CD4 + and CD8 + T cells in the BOLT-treated group, with a significant increase observed in CD8 + T cells. Student t-test was performed for comparison between the two groups. Two-way ANOVA was used for multiple comparisons. Data represent the mean ± SEM (n = 5). ∗ p < 0.05, ∗∗ p < 0.01.

    Techniques Used: Control, In Vivo Imaging, Flow Cytometry, Comparison

    Combinational treatment of BOLT and anti-CTLA-4 blockade enhances anti-tumor immune response in B16 melanoma. (A) C57BL/6 mice were subcutaneously injected with 1 × 10 5 B16 melanoma cells on day 0 to induce tumors. On day 7, mice were randomly divided into groups and treated with either BOLT alone (intratumoral injection administered on alternate days starting from day 7), anti-CTLA-4 (intraperitoneal injection administered on days 9, 11, 13, and 15), or a combination of both treatments. PBS was used as a vehicle Control, while IgG was used as anti-CTLA-4 Control. Tumor growth was monitored throughout the treatment period, and tumors were harvested for analysis on day 21. (B-C) Tumor growth curves and area under the curve (AUC) analysis for WT mice treated with BOLT, with or without anti-CTLA-4 antibody, following subcutaneous injection of B16 melanoma cells. Tumor growth was monitored, and analysis was conducted on day 21. (D) Representative images of excised tumors at day 21, showed reduced tumor size in combination-treated mice. (E, F) Flow cytometry analysis of IFN-γ production by tumor-infiltrating CD4 + and CD8 + T cells. (G, H) Flow cytometry analysis of TNF-α production by tumor-infiltrating CD4 + and CD8 + T cells. Two-way ANOVA was used for multiple comparisons. Data are mean ± SEM (n = 5), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001.
    Figure Legend Snippet: Combinational treatment of BOLT and anti-CTLA-4 blockade enhances anti-tumor immune response in B16 melanoma. (A) C57BL/6 mice were subcutaneously injected with 1 × 10 5 B16 melanoma cells on day 0 to induce tumors. On day 7, mice were randomly divided into groups and treated with either BOLT alone (intratumoral injection administered on alternate days starting from day 7), anti-CTLA-4 (intraperitoneal injection administered on days 9, 11, 13, and 15), or a combination of both treatments. PBS was used as a vehicle Control, while IgG was used as anti-CTLA-4 Control. Tumor growth was monitored throughout the treatment period, and tumors were harvested for analysis on day 21. (B-C) Tumor growth curves and area under the curve (AUC) analysis for WT mice treated with BOLT, with or without anti-CTLA-4 antibody, following subcutaneous injection of B16 melanoma cells. Tumor growth was monitored, and analysis was conducted on day 21. (D) Representative images of excised tumors at day 21, showed reduced tumor size in combination-treated mice. (E, F) Flow cytometry analysis of IFN-γ production by tumor-infiltrating CD4 + and CD8 + T cells. (G, H) Flow cytometry analysis of TNF-α production by tumor-infiltrating CD4 + and CD8 + T cells. Two-way ANOVA was used for multiple comparisons. Data are mean ± SEM (n = 5), ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001.

    Techniques Used: Injection, Control, Flow Cytometry

    Related Articles

    Isolation:

    Article Title: Protocol for potent activation of T cells using BPI-stimulated murine bone marrow-derived cells
    Article Snippet: .. • To analyze (naïve) CD8 + T cells, use the murine “naïve CD8a + T-Cell Isolation Kit” from Miltenyi Biotech (130-096-543) in steps 10 and 11. ..

    Article Title: E4BP4 restrains effector-memory CD8 + T cell responses in systemic lupus erythematosus.
    Article Snippet: .. We isolated naïve CD8+ T cells from the spleen and lymph nodes of CD45.1+ OT-I mice and E4bp4−/−OTI mice, using Mouse Nave CD8a+T Cell Isolation Kit (Miltenyi Biotec, # 130-096-543), and the entire process followed the instructions. .. We isolated naïve CD8+ T cells from the spleen and lymph nodes of CD45.1+ OT-I mice and E4bp4−/−OTI mice, using Mouse Nave CD8a+T Cell Isolation Kit (Miltenyi Biotec, # 130-096-543), and the entire process followed the instructions.

    Article Title: Enzymatic attachment of antigens to probe immune modulation by skin commensals
    Article Snippet: After spinning the splenocytes at 550 g for 5 min at 4 °C, the red blood cells were lysed using 1 ml of Ack lysis buffer for 5 min at room temperature (Thermo Scientific, # A1049201). .. T cells were then isolated using naïve CD4 and CD8 T cell isolation kits, where appropriate following manufacturing guidelines (Milteny, 130-104-453 or 130-096-543). .. T cells were then counted and rested for at least 30 min in complete RPMI (cRPMI = RPMI (Thermo Fisher, 61870127) supplemented with Penicillin-Streptomycin (Thermo Fisher, 15140122), HEPES (Thermo Fisher, 15630080), non-essential amino acids (Thermo Fisher, 11140050), sodium pyruvate (Thermo Fisher, 11360070), β-mercaptoethanol (Life Technologies Corporation, 21985023) and 10% FBS (GeminiBio)).

    Purification:

    Article Title: Therapeutic Poxviruses Induce the Secretion of Immunostimulating and Anti‐Tumoral Extracellular Vesicles
    Article Snippet: .. Naïve CD8 + T cells were purified with a mouse Naïve CD8a + T cell Isolation Kit (MiltenyiBiotec #130‐096‐543). .. Purified naïve CD8 + T cells purity was assessed by flow cytometry on a Attune NxT (Invitrogen) flow cytometer using FITC anti‐CD4 (1:100, clone RM4‐5, BioLegend #100510), BV605 anti‐CD8 (1:200, clone 53–6.7, BioLegend #100743), PE anti‐CD44 (1:200, clone IM7, BioLegend #103024), PE‐Cy7 anti‐TCR Va2 (1:100, clone B20.1, BioLegend #103024), and APC anti‐TCR Vb5.1, 5.2 (1:100, clone MR9‐4, BioLegend #139506) staining and ranged from 95.7 to 99.8 (median 99.3%).

    Article Title: pH-neutralization strategy to suppress GPCR68 spatiotemporally activates T cells and enhances anti-tumor immunity
    Article Snippet: The mice were anesthetized intraperitoneally with tribromoethanol (# T48402 , Sigma). .. Naïve T cells were purified from lymph nodes as well as spleens of C57/BL6, CD4 Cre , GPCR68 fl/fl CD4 Cre (CKO) mice by using the mouse naïve CD4 + T Cell Isolation Kit (#130-104-453; Miltenyi Biotec) or naïve CD8 + T Cell Isolation Kit (#130-096-543; Miltenyi Biotec) for negative selection. .. Cells were stimulated with anti-CD3/CD28 antibodies (2 and 1 μg/well, respectively, #BE0001/BE0015, Bioxcell) and IL-2 (50U, #202-IL-050, R&D) in a 24-well plate in complete RPMI-1640 medium containing 10% FBS, 1% penicillin/streptomycin, 1% glutamine, 1% Sodium Pyruvate, 1% non-essential amino acids, and 0.1% β-mercaptoethanol for 3-5days.

    Cell Isolation:

    Article Title: Therapeutic Poxviruses Induce the Secretion of Immunostimulating and Anti‐Tumoral Extracellular Vesicles
    Article Snippet: .. Naïve CD8 + T cells were purified with a mouse Naïve CD8a + T cell Isolation Kit (MiltenyiBiotec #130‐096‐543). .. Purified naïve CD8 + T cells purity was assessed by flow cytometry on a Attune NxT (Invitrogen) flow cytometer using FITC anti‐CD4 (1:100, clone RM4‐5, BioLegend #100510), BV605 anti‐CD8 (1:200, clone 53–6.7, BioLegend #100743), PE anti‐CD44 (1:200, clone IM7, BioLegend #103024), PE‐Cy7 anti‐TCR Va2 (1:100, clone B20.1, BioLegend #103024), and APC anti‐TCR Vb5.1, 5.2 (1:100, clone MR9‐4, BioLegend #139506) staining and ranged from 95.7 to 99.8 (median 99.3%).

    Article Title: Inhibition of integrin αvβ8-mediated TGFβ activation and active-TGFβ blockade promote anti-tumor immunity through distinct biological mechanisms
    Article Snippet: 20,000 DCs were seeded into a 96 well U-bottom plate in 150μL of complete RPMI media (10% heat-inactivated fetal bovine serum, 2mM Glutamax, and 100U/mL Penicillin-Streptomycin) containing 10μg/mL of ovalbumin (InvivoGen, Cat no. vac-pova), or media alone for 2 hours at 37°C. .. To isolate ovalbumin-specific CD8 + T cells, spleens from female OT-1 mice (Jackson Laboratory, strain 003831) were collected, mashed through a 70um strainer, and single cell suspensions were stained with the Naïve CD8a + T cell Isolation Kit (Miltenyi, Cat no. 130-096-543). .. Naïve CD8a + T cells were isolated according to manufacturer’s instructions and stained with a 4μM solution of CellTrace Violet (Invitrogen, Cat no. C34557) in PBS.

    Article Title: E4BP4 restrains effector-memory CD8 + T cell responses in systemic lupus erythematosus.
    Article Snippet: .. We isolated naïve CD8+ T cells from the spleen and lymph nodes of CD45.1+ OT-I mice and E4bp4−/−OTI mice, using Mouse Nave CD8a+T Cell Isolation Kit (Miltenyi Biotec, # 130-096-543), and the entire process followed the instructions. .. We isolated naïve CD8+ T cells from the spleen and lymph nodes of CD45.1+ OT-I mice and E4bp4−/−OTI mice, using Mouse Nave CD8a+T Cell Isolation Kit (Miltenyi Biotec, # 130-096-543), and the entire process followed the instructions.

    Article Title: pH-neutralization strategy to suppress GPCR68 spatiotemporally activates T cells and enhances anti-tumor immunity
    Article Snippet: The mice were anesthetized intraperitoneally with tribromoethanol (# T48402 , Sigma). .. Naïve T cells were purified from lymph nodes as well as spleens of C57/BL6, CD4 Cre , GPCR68 fl/fl CD4 Cre (CKO) mice by using the mouse naïve CD4 + T Cell Isolation Kit (#130-104-453; Miltenyi Biotec) or naïve CD8 + T Cell Isolation Kit (#130-096-543; Miltenyi Biotec) for negative selection. .. Cells were stimulated with anti-CD3/CD28 antibodies (2 and 1 μg/well, respectively, #BE0001/BE0015, Bioxcell) and IL-2 (50U, #202-IL-050, R&D) in a 24-well plate in complete RPMI-1640 medium containing 10% FBS, 1% penicillin/streptomycin, 1% glutamine, 1% Sodium Pyruvate, 1% non-essential amino acids, and 0.1% β-mercaptoethanol for 3-5days.

    Article Title: Enzymatic attachment of antigens to probe immune modulation by skin commensals
    Article Snippet: After spinning the splenocytes at 550 g for 5 min at 4 °C, the red blood cells were lysed using 1 ml of Ack lysis buffer for 5 min at room temperature (Thermo Scientific, # A1049201). .. T cells were then isolated using naïve CD4 and CD8 T cell isolation kits, where appropriate following manufacturing guidelines (Milteny, 130-104-453 or 130-096-543). .. T cells were then counted and rested for at least 30 min in complete RPMI (cRPMI = RPMI (Thermo Fisher, 61870127) supplemented with Penicillin-Streptomycin (Thermo Fisher, 15140122), HEPES (Thermo Fisher, 15630080), non-essential amino acids (Thermo Fisher, 11140050), sodium pyruvate (Thermo Fisher, 11360070), β-mercaptoethanol (Life Technologies Corporation, 21985023) and 10% FBS (GeminiBio)).

    Article Title: Host Metadherin Coordinates Hepatic Lipid metabolism and CD8 + T-Cell Immunity to Promote Tumor Progression
    Article Snippet: Standard Macrophage Depletion Kit (Clodrosome + Encapsome) , Encapsula NanoSciences , Cat#CLD-8901. .. Naive CD8a+ T Cell Isolation Kit, mouse , Miltenyi Biotec , Cat#130-096-543. .. CD8a+ T Cell Isolation Kit, mouse , Miltenyi Biotec , Cat#130-104-075.

    Single Cell:

    Article Title: Inhibition of integrin αvβ8-mediated TGFβ activation and active-TGFβ blockade promote anti-tumor immunity through distinct biological mechanisms
    Article Snippet: 20,000 DCs were seeded into a 96 well U-bottom plate in 150μL of complete RPMI media (10% heat-inactivated fetal bovine serum, 2mM Glutamax, and 100U/mL Penicillin-Streptomycin) containing 10μg/mL of ovalbumin (InvivoGen, Cat no. vac-pova), or media alone for 2 hours at 37°C. .. To isolate ovalbumin-specific CD8 + T cells, spleens from female OT-1 mice (Jackson Laboratory, strain 003831) were collected, mashed through a 70um strainer, and single cell suspensions were stained with the Naïve CD8a + T cell Isolation Kit (Miltenyi, Cat no. 130-096-543). .. Naïve CD8a + T cells were isolated according to manufacturer’s instructions and stained with a 4μM solution of CellTrace Violet (Invitrogen, Cat no. C34557) in PBS.

    Staining:

    Article Title: Inhibition of integrin αvβ8-mediated TGFβ activation and active-TGFβ blockade promote anti-tumor immunity through distinct biological mechanisms
    Article Snippet: 20,000 DCs were seeded into a 96 well U-bottom plate in 150μL of complete RPMI media (10% heat-inactivated fetal bovine serum, 2mM Glutamax, and 100U/mL Penicillin-Streptomycin) containing 10μg/mL of ovalbumin (InvivoGen, Cat no. vac-pova), or media alone for 2 hours at 37°C. .. To isolate ovalbumin-specific CD8 + T cells, spleens from female OT-1 mice (Jackson Laboratory, strain 003831) were collected, mashed through a 70um strainer, and single cell suspensions were stained with the Naïve CD8a + T cell Isolation Kit (Miltenyi, Cat no. 130-096-543). .. Naïve CD8a + T cells were isolated according to manufacturer’s instructions and stained with a 4μM solution of CellTrace Violet (Invitrogen, Cat no. C34557) in PBS.

    Selection:

    Article Title: pH-neutralization strategy to suppress GPCR68 spatiotemporally activates T cells and enhances anti-tumor immunity
    Article Snippet: The mice were anesthetized intraperitoneally with tribromoethanol (# T48402 , Sigma). .. Naïve T cells were purified from lymph nodes as well as spleens of C57/BL6, CD4 Cre , GPCR68 fl/fl CD4 Cre (CKO) mice by using the mouse naïve CD4 + T Cell Isolation Kit (#130-104-453; Miltenyi Biotec) or naïve CD8 + T Cell Isolation Kit (#130-096-543; Miltenyi Biotec) for negative selection. .. Cells were stimulated with anti-CD3/CD28 antibodies (2 and 1 μg/well, respectively, #BE0001/BE0015, Bioxcell) and IL-2 (50U, #202-IL-050, R&D) in a 24-well plate in complete RPMI-1640 medium containing 10% FBS, 1% penicillin/streptomycin, 1% glutamine, 1% Sodium Pyruvate, 1% non-essential amino acids, and 0.1% β-mercaptoethanol for 3-5days.



    Similar Products

    98
    New England Biolabs monarch spin rna isolation kit
    Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Monarch Spin Rna Isolation Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/Monarch+Spin+RNA+Isolation+Kit/pmc13768812-165-18-23
    Average 98 stars, based on 1 article reviews
    monarch spin rna isolation kit - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    97
    Vazyme Biotech Co fertilization
    Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Fertilization, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/FastPure+Plant+Total+RNA+Isolation+Kit/pmc13763932-144-57-70
    Average 97 stars, based on 1 article reviews
    fertilization - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    86
    Thermo Fisher purelink mirna isolation kit
    Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Purelink Mirna Isolation Kit, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/nct04488614-6-7-11
    Average 86 stars, based on 1 article reviews
    purelink mirna isolation kit - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    97
    Vazyme Biotech Co dna isolation kit
    Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Dna Isolation Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/FastPure+Cell+Tissue+DNA+Isolation+Mini+Kit/pmc13766282-59-9-12
    Average 97 stars, based on 1 article reviews
    dna isolation kit - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    Vazyme Biotech Co fastpure blood cell tissue
    Transcriptome-wide mapping and biochemical characterization of RhsP2 <t>RNA</t> recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).
    Fastpure Blood Cell Tissue, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/FastPure+Blood+Cell+Tissue+Bacteria+DNA+Isolation+Mini+Kit/pmc13757092-107-10-17
    Average 96 stars, based on 1 article reviews
    fastpure blood cell tissue - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Vazyme Biotech Co mouse cd8 t cell isolation kit
    Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated <t>CD8</t> + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Mouse Cd8 T Cell Isolation Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/Mouse+CD8%2B+T+Cell+Isolation+Kit/pmc13752232-360-11-19
    Average 94 stars, based on 1 article reviews
    mouse cd8 t cell isolation kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    Vazyme Biotech Co super fastpure cell rna isolation kit
    Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated <t>CD8</t> + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Super Fastpure Cell Rna Isolation Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/FastPure+Cell+Tissue+Total+RNA+Isolation+Kit+V2/pm42962328-179-6-12
    Average 99 stars, based on 1 article reviews
    super fastpure cell rna isolation kit - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Vazyme Biotech Co fastpure cell tissue total rna isolation kit v2
    Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated <t>CD8</t> + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Fastpure Cell Tissue Total Rna Isolation Kit V2, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/FastPure+Cell+Tissue+Total+RNA+Isolation+Kit+V2/pmc13748770-328-5-12
    Average 99 stars, based on 1 article reviews
    fastpure cell tissue total rna isolation kit v2 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Zymo Research rna isolation
    Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated <t>CD8</t> + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Rna Isolation, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/Quick-RNA+Microprep+Kit/pmc13757599-91-12-15
    Average 99 stars, based on 1 article reviews
    rna isolation - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    Norgen Biotek plant fungi dna isolation kit
    Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated <t>CD8</t> + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Plant Fungi Dna Isolation Kit, supplied by Norgen Biotek, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/isolation+kit/Plant+DNA+Isolation+Kit/pmc13745392-8-13-12
    Average 96 stars, based on 1 article reviews
    plant fungi dna isolation kit - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Transcriptome-wide mapping and biochemical characterization of RhsP2 RNA recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).

    Journal: Nucleic Acids Research

    Article Title: An RNA-targeting ADP-ribosyltransferase toxin uncouples mRNA stability from productive translation

    doi: 10.1093/nar/gkag1177

    Figure Lengend Snippet: Transcriptome-wide mapping and biochemical characterization of RhsP2 RNA recognition and ADP-ribosylation. ( A ) Schematic of the eCLIP-seq workflow used to map RhsP2-associated RNAs. Cells expressing FLAG-tagged, catalytically inactive RhsP2* were UV-crosslinked, lysed, and subjected to anti-FLAG immunoprecipitation. Crosslinked RNA fragments associated with RhsP2* were recovered following SDS–PAGE separation, converted into complementary DNA (cDNA) libraries containing unique molecular identifiers, and sequenced. ( B ) Representative genome-browser view of RhsP2* eCLIP-seq signal at a target locus. IP and matched input tracks are shown. The shaded region highlights a representative RhsP2*-enriched peak, with the local sequence shown below. ( C ) Genomic annotation of RhsP2* eCLIP-seq peaks across transcript features. The bar plot shows the fraction of called peaks assigned to CDSs, 5′ UTRs, 3′ UTRs, tRNAs, sRNAs, rRNAs, and intergenic regions. ( D ) De novo motif analysis of RhsP2* eCLIP-seq peaks. Two enriched UAA-centered motifs identified from RhsP2* eCLIP-seq peaks are shown, including a highly enriched UAAG-containing motif. The percentage of peaks containing each motif and the associated enrichment P -value are shown. ( E ) Schematic of the Cy3-labeled synthetic RNA substrate used for biochemical validation and site-mapping experiments. The UAAG motif is highlighted in green, and nucleotide positions used for RNase T1 and alkaline hydrolysis (AH) mapping are indicated. ( F ) Biochemical evaluation of motif-dependent RNA recognition and modification. Top, EMSA evaluating the binding of catalytically inactive RhsP2* to RNA substrates containing the indicated motif variants. RNA substrates were incubated with increasing concentrations of purified RhsP2* (0–10 µM). Free RNA and protein-bound RNA species are indicated. Bottom, in vitro ADP-ribosylation of the corresponding RNA substrates. Reactions were performed with 1 mM NAD⁺ in the absence or presence of 0.1 µM purified WT RhsP2 for 10 s, and reaction products were resolved by denaturing urea-PAGE. Unmodified RNA and slower-migrating ADP-ribosylated RNA (ADPr-RNA) species are indicated. ( G ) AH and RNase T1 mapping of purified ADPr-RNA. Unmodified control RNA (Ctrl) and ADPr-RNA were subjected to AH, and RNase T1 digestion was used as a nucleotide reference ladder. The red AH label denotes the AH lane generated from ADPr-RNA. The green bar marks the UAAG-containing region that is protected from alkaline cleavage following ADP-ribosylation. Numbers indicate nucleotide positions within the synthetic RNA substrate shown in panel (E).

    Article Snippet: To determine the expression of the genes in toxin-induced and control conditions, total RNA was isolated using the Monarch Spin RNA Isolation Kit (NEB) according to the manufacturer’s instructions.

    Techniques: Cross-linking Immunoprecipitation, Expressing, Immunoprecipitation, SDS Page, Sequencing, Analysis, Labeling, Biomarker Discovery, Modification, Binding Assay, Incubation, Purification, In Vitro, Urea-PAGE, Control, Generated, cDNA Library Assay

    RhsP2 stabilizes target mRNAs while uncoupling transcript persistence from productive protein synthesis. ( A ) Workflow for transcriptome-wide mRNA half-life measurements by rifampicin-chase RNA-seq (RIF-seq). Following RhsP2 induction or empty-vector control treatment, transcription was inhibited with rifampicin, and cells were harvested at 0, 2, 6, and 12 min for RNA extraction, RNA-seq, and half-life estimation. n = 3 biological replicates. ( B ) Genome-wide distribution of mRNA half-lives in control and RhsP2-induced cells. Half-lives are plotted as log 2 -transformed values. Statistical significance was assessed using a two-sided Wilcoxon rank-sum test within each condition; **** P ≤ .0001. ( C ) Motif-stratified analysis of transcriptome-wide mRNA half-lives. Transcripts were grouped according to the presence or absence of UAAG motif within CDSs, and transcript half-lives were compared between groups. Statistical comparisons are indicated. Statistical significance was assessed using a two-sided Wilcoxon rank-sum test within each condition. ns, not significant; **** P ≤ .0001. ( D ) Genome-browser view of the cspE locus showing RhsP2* eCLIP-seq enrichment in the IP sample relative to matched input. UAAG-related motif occurrences (shown as TAAG in DNA notation) are boxed. cspE was selected as a representative RhsP2-associated transcript for independent validation. ( E ) RNA-seq coverage tracks across the cspE locus during the rifampicin-chase time course. Tracks are shown at 0, 2, 6, and 12 min after rifampicin addition for control and RhsP2-induced cells. ( F ) qRT-PCR validation of cspE mRNA decay following rifampicin treatment. Relative cspE mRNA levels are shown over time in control and RhsP2-induced cells. ( G ) Schematic of the tagged reporter used to measure regional differences in RhsP2-dependent RNA stabilization and protein output. Reporter constructs contain a variable insert comprising a stop sequence, a no-stop control sequence, or a UAAG motif cassette upstream of a C-terminal 3 × FLAG tag. Primer set 1 interrogates the upstream mclover3 region distal to the variable insert, whereas primer set 2 interrogates the motif-proximal region. (H–J) Rifampicin-chase qRT-PCR validation of reporter mRNA decay using primer set 1, which detects the distal mclover3 region indicated in panel (G). Relative reporter mRNA levels are shown over time for transcripts containing a stop control ( H ), a no-stop insert ( I ), and 6 × GUAAGA motif cassette ( J ) under control and RhsP2-induced conditions. ( K ) Rifampicin-chase qRT-PCR analysis of the 6 × GUAAGA motif-containing reporter using primer set 2, which detects the motif-proximal region indicated in panel (G). Relative reporter mRNA abundance is shown over time under control and RhsP2-induced conditions. For panels (H–K), statistical significance was assessed using two-way analysis of variance (ANOVA) followed by Šídák’s multiple-comparisons test comparing control and RhsP2-induced conditions at each time point. * P ≤ .05, ** P ≤ .01, *** P ≤ .001. ( L ) Anti-FLAG immunoblot analysis of reporter protein accumulation under control and RhsP2-induced conditions. A nonspecific band is shown below as a loading control.

    Journal: Nucleic Acids Research

    Article Title: An RNA-targeting ADP-ribosyltransferase toxin uncouples mRNA stability from productive translation

    doi: 10.1093/nar/gkag1177

    Figure Lengend Snippet: RhsP2 stabilizes target mRNAs while uncoupling transcript persistence from productive protein synthesis. ( A ) Workflow for transcriptome-wide mRNA half-life measurements by rifampicin-chase RNA-seq (RIF-seq). Following RhsP2 induction or empty-vector control treatment, transcription was inhibited with rifampicin, and cells were harvested at 0, 2, 6, and 12 min for RNA extraction, RNA-seq, and half-life estimation. n = 3 biological replicates. ( B ) Genome-wide distribution of mRNA half-lives in control and RhsP2-induced cells. Half-lives are plotted as log 2 -transformed values. Statistical significance was assessed using a two-sided Wilcoxon rank-sum test within each condition; **** P ≤ .0001. ( C ) Motif-stratified analysis of transcriptome-wide mRNA half-lives. Transcripts were grouped according to the presence or absence of UAAG motif within CDSs, and transcript half-lives were compared between groups. Statistical comparisons are indicated. Statistical significance was assessed using a two-sided Wilcoxon rank-sum test within each condition. ns, not significant; **** P ≤ .0001. ( D ) Genome-browser view of the cspE locus showing RhsP2* eCLIP-seq enrichment in the IP sample relative to matched input. UAAG-related motif occurrences (shown as TAAG in DNA notation) are boxed. cspE was selected as a representative RhsP2-associated transcript for independent validation. ( E ) RNA-seq coverage tracks across the cspE locus during the rifampicin-chase time course. Tracks are shown at 0, 2, 6, and 12 min after rifampicin addition for control and RhsP2-induced cells. ( F ) qRT-PCR validation of cspE mRNA decay following rifampicin treatment. Relative cspE mRNA levels are shown over time in control and RhsP2-induced cells. ( G ) Schematic of the tagged reporter used to measure regional differences in RhsP2-dependent RNA stabilization and protein output. Reporter constructs contain a variable insert comprising a stop sequence, a no-stop control sequence, or a UAAG motif cassette upstream of a C-terminal 3 × FLAG tag. Primer set 1 interrogates the upstream mclover3 region distal to the variable insert, whereas primer set 2 interrogates the motif-proximal region. (H–J) Rifampicin-chase qRT-PCR validation of reporter mRNA decay using primer set 1, which detects the distal mclover3 region indicated in panel (G). Relative reporter mRNA levels are shown over time for transcripts containing a stop control ( H ), a no-stop insert ( I ), and 6 × GUAAGA motif cassette ( J ) under control and RhsP2-induced conditions. ( K ) Rifampicin-chase qRT-PCR analysis of the 6 × GUAAGA motif-containing reporter using primer set 2, which detects the motif-proximal region indicated in panel (G). Relative reporter mRNA abundance is shown over time under control and RhsP2-induced conditions. For panels (H–K), statistical significance was assessed using two-way analysis of variance (ANOVA) followed by Šídák’s multiple-comparisons test comparing control and RhsP2-induced conditions at each time point. * P ≤ .05, ** P ≤ .01, *** P ≤ .001. ( L ) Anti-FLAG immunoblot analysis of reporter protein accumulation under control and RhsP2-induced conditions. A nonspecific band is shown below as a loading control.

    Article Snippet: To determine the expression of the genes in toxin-induced and control conditions, total RNA was isolated using the Monarch Spin RNA Isolation Kit (NEB) according to the manufacturer’s instructions.

    Techniques: RNA Sequencing, Plasmid Preparation, Control, RNA Extraction, Genome Wide, Transformation Assay, Analysis, Cross-linking Immunoprecipitation, Biomarker Discovery, Quantitative RT-PCR, Construct, Sequencing, FLAG-tag, Western Blot

    RhsP2 induces ribosome pausing during translation elongation. Representative sucrose-gradient A254 profiles of RhsP2-induced ( A ) or control ( B ) cells showing 30S, 50S, 70S, and polysome fractions. ( C ) Schematic of the monosome and disome footprinting workflow following MNase digestion and sucrose-gradient fractionation. Monosome (M) and disome (D) fractions were collected for RPF isolation and sequencing. ( D ) Denaturing urea-PAGE analysis of RPFs recovered from monosome (M) and disome (D) fractions. Samples from control and RhsP2-induced cells were analyzed with or without MNase treatment as indicated. Two biological replicates are shown for each condition. Red triangles indicate canonical monosome-sized RPFs, whereas red circles indicate slower-migrating RPF species, and dashed boxes indicate the RNA size ranges excised for library preparation. ( E ) Top: schematic representation of a UAA-containing sequence positioned within the ribosomal P-site. Bottom: codons generated from the UAA motif in different reading frames. ( F ) Codon-level pause scores for UAA-derived codon contexts in control and RhsP2-induced cells. Pause scores are elevated in RhsP2-induced samples across multiple motif-derived codon classes. ( G ) Representative genome-browser view of mono-seq coverage across the cspE locus in RhsP2-induced and control cells. Boxed TAAG sequences indicate UAAG-containing sites in the corresponding RNA transcript.

    Journal: Nucleic Acids Research

    Article Title: An RNA-targeting ADP-ribosyltransferase toxin uncouples mRNA stability from productive translation

    doi: 10.1093/nar/gkag1177

    Figure Lengend Snippet: RhsP2 induces ribosome pausing during translation elongation. Representative sucrose-gradient A254 profiles of RhsP2-induced ( A ) or control ( B ) cells showing 30S, 50S, 70S, and polysome fractions. ( C ) Schematic of the monosome and disome footprinting workflow following MNase digestion and sucrose-gradient fractionation. Monosome (M) and disome (D) fractions were collected for RPF isolation and sequencing. ( D ) Denaturing urea-PAGE analysis of RPFs recovered from monosome (M) and disome (D) fractions. Samples from control and RhsP2-induced cells were analyzed with or without MNase treatment as indicated. Two biological replicates are shown for each condition. Red triangles indicate canonical monosome-sized RPFs, whereas red circles indicate slower-migrating RPF species, and dashed boxes indicate the RNA size ranges excised for library preparation. ( E ) Top: schematic representation of a UAA-containing sequence positioned within the ribosomal P-site. Bottom: codons generated from the UAA motif in different reading frames. ( F ) Codon-level pause scores for UAA-derived codon contexts in control and RhsP2-induced cells. Pause scores are elevated in RhsP2-induced samples across multiple motif-derived codon classes. ( G ) Representative genome-browser view of mono-seq coverage across the cspE locus in RhsP2-induced and control cells. Boxed TAAG sequences indicate UAAG-containing sites in the corresponding RNA transcript.

    Article Snippet: To determine the expression of the genes in toxin-induced and control conditions, total RNA was isolated using the Monarch Spin RNA Isolation Kit (NEB) according to the manufacturer’s instructions.

    Techniques: Control, Footprinting, Micrococcal Nuclease Digestion, Gradient Centrifugation, Isolation, Sequencing, Urea-PAGE, Analysis, Generated, Derivative Assay, Ribosome Profiling

    ADP-ribosylated mRNA blocks productive translation in vitro . ( A ) Schematic of the dual-tag reporter used to monitor translation completion in vitro . The reporter contains an N-terminal V5 tag, mClover, a variable insert region, and a C-terminal 3 × FLAG tag. Full-length translation generates V5- and FLAG-positive products, whereas translational arrest upstream of the C-terminal tag generates V5-positive, FLAG-negative products. As a positive control for translational arrest, the variable insert region contained the C-terminal SecM arrest peptide sequence FSTPVWISQAQGIRAGP. ( B ) Anti-V5 and anti-FLAG immunoblots of in vitro translation products generated from the indicated reporter RNAs. Red arrowheads indicate the expected primary translation products; red circles indicate arrested or truncated products. ( C ) Workflow for in vitro translation and ribosome complex fractionation. Unmodified or ADP-ribosylated reporter mRNAs were translated using the PURExpress system at 37°C for 60 min, treated with or without MNase, separated on 10%–50% sucrose gradients, and analyzed following fraction collection. A254 sucrose gradient profiles (upper) and corresponding anti-V5 immunoblots of gradient fractions (lower) from translation reactions containing unmodified 6 × UAAG-containing RNA ( D ), ADP-ribosylated 6 × UAAG-containing RNA ( E ), or SecM arrest peptide-encoding control RNA ( F ), with or without MNase treatment. Insets show zoomed-in views of the disome-associated regions indicated by the dashed boxes. ( G ) Anti-ADPr immunoblot analysis of purified RNA recovered from monosome- and disome-associated fractions following in vitro translation and MNase treatment.

    Journal: Nucleic Acids Research

    Article Title: An RNA-targeting ADP-ribosyltransferase toxin uncouples mRNA stability from productive translation

    doi: 10.1093/nar/gkag1177

    Figure Lengend Snippet: ADP-ribosylated mRNA blocks productive translation in vitro . ( A ) Schematic of the dual-tag reporter used to monitor translation completion in vitro . The reporter contains an N-terminal V5 tag, mClover, a variable insert region, and a C-terminal 3 × FLAG tag. Full-length translation generates V5- and FLAG-positive products, whereas translational arrest upstream of the C-terminal tag generates V5-positive, FLAG-negative products. As a positive control for translational arrest, the variable insert region contained the C-terminal SecM arrest peptide sequence FSTPVWISQAQGIRAGP. ( B ) Anti-V5 and anti-FLAG immunoblots of in vitro translation products generated from the indicated reporter RNAs. Red arrowheads indicate the expected primary translation products; red circles indicate arrested or truncated products. ( C ) Workflow for in vitro translation and ribosome complex fractionation. Unmodified or ADP-ribosylated reporter mRNAs were translated using the PURExpress system at 37°C for 60 min, treated with or without MNase, separated on 10%–50% sucrose gradients, and analyzed following fraction collection. A254 sucrose gradient profiles (upper) and corresponding anti-V5 immunoblots of gradient fractions (lower) from translation reactions containing unmodified 6 × UAAG-containing RNA ( D ), ADP-ribosylated 6 × UAAG-containing RNA ( E ), or SecM arrest peptide-encoding control RNA ( F ), with or without MNase treatment. Insets show zoomed-in views of the disome-associated regions indicated by the dashed boxes. ( G ) Anti-ADPr immunoblot analysis of purified RNA recovered from monosome- and disome-associated fractions following in vitro translation and MNase treatment.

    Article Snippet: To determine the expression of the genes in toxin-induced and control conditions, total RNA was isolated using the Monarch Spin RNA Isolation Kit (NEB) according to the manufacturer’s instructions.

    Techniques: In Vitro, FLAG-tag, Positive Control, Sequencing, Western Blot, In Vitro Translation, Generated, Fractionation, Control, Analysis, Purification

    Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated CD8 + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated CD8 + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: OT‐I cells were isolated from OT‐I transgenic mouse spleens using the Mouse CD8 + T Cell Isolation Kit (CS103‐01, Vazyme) and labeled with eFluor 670 dye (65‐0840‐85, eBioscience).

    Techniques: CCK-8 Assay, Activation Assay, Expressing, Quantitative RT-PCR, Morphology, Dynamic Light Scattering Assay, Transmission Assay, Electron Microscopy, Elemental Analysis, Confocal, Imaging, Labeling, Staining, Fluorescence, Incubation

    NAD + supplementation protects MSCs from death and boosts their anti‐inflammatory potential in vivo. (A) The reduction in cell viability of MSCs after IT treatment can be reversed by the addition of 25 µM NANP ( n = 3). (B) TMRE staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, presented as cytofluorometric dot plots and statistical analysis ( n = 3). (C) Annexin V/DAPI dual staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, shown as cytofluorometric dot plots and statistical analysis ( n = 3). (D) MSCs treated with 25 µM NANP, IT, or their combination for 48 h, the expression of apoptosis executors (CASP3 and cleaved CASP3), and necroptosis executors (RIPK3 and p‐RIPK3) was measured by semiquantitative WB. (E) 25 µM NANP restores the ability of 5‐days IT‐treated MSCs to inhibit anti‐CD3/CD28‐stimulated CD8 + T cell proliferation. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (F) Schematic diagram showing the preparation of NAD + ‐loaded MSCs. (G) Schematic diagram showing the MSCs‐treated IBD model. (H) Body weight measurements of IBD mice were administered either MSCs or NAD + ‐loaded MSCs ( n = 5). (I) Colon length of IBD mice and quantitative analysis compared between DSS, MSCs, and NAD + ‐loaded MSCs ( n = 5). (J) Representative H&E‐stained colon sections and histological scores of IBD mice administered by MSCs or NAD + ‐loaded MSCs ( n = 5). (K) IVIS imaging of colon tissues. The mice were euthanized at 48 h after administration, and the colon was immediately removed for imaging with an IVIS Lumina Series (left panel). Average radiant efficiency was compared between MSCs and NAD + ‐loaded MSCs (right panel) ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NAD + supplementation protects MSCs from death and boosts their anti‐inflammatory potential in vivo. (A) The reduction in cell viability of MSCs after IT treatment can be reversed by the addition of 25 µM NANP ( n = 3). (B) TMRE staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, presented as cytofluorometric dot plots and statistical analysis ( n = 3). (C) Annexin V/DAPI dual staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, shown as cytofluorometric dot plots and statistical analysis ( n = 3). (D) MSCs treated with 25 µM NANP, IT, or their combination for 48 h, the expression of apoptosis executors (CASP3 and cleaved CASP3), and necroptosis executors (RIPK3 and p‐RIPK3) was measured by semiquantitative WB. (E) 25 µM NANP restores the ability of 5‐days IT‐treated MSCs to inhibit anti‐CD3/CD28‐stimulated CD8 + T cell proliferation. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (F) Schematic diagram showing the preparation of NAD + ‐loaded MSCs. (G) Schematic diagram showing the MSCs‐treated IBD model. (H) Body weight measurements of IBD mice were administered either MSCs or NAD + ‐loaded MSCs ( n = 5). (I) Colon length of IBD mice and quantitative analysis compared between DSS, MSCs, and NAD + ‐loaded MSCs ( n = 5). (J) Representative H&E‐stained colon sections and histological scores of IBD mice administered by MSCs or NAD + ‐loaded MSCs ( n = 5). (K) IVIS imaging of colon tissues. The mice were euthanized at 48 h after administration, and the colon was immediately removed for imaging with an IVIS Lumina Series (left panel). Average radiant efficiency was compared between MSCs and NAD + ‐loaded MSCs (right panel) ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: OT‐I cells were isolated from OT‐I transgenic mouse spleens using the Mouse CD8 + T Cell Isolation Kit (CS103‐01, Vazyme) and labeled with eFluor 670 dye (65‐0840‐85, eBioscience).

    Techniques: In Vivo, Staining, Analysis, Expressing, Imaging

    NANP‐primed MSCs reprogram colitic immunity by restraining inflammatory trafficking. (A) Proportion of CD45 + immune cells in the colon tissues of IBD mice, 6 days post‐MSCs therapy ( n = 6). (B) Distribution of major colonic immune cell subsets, quantified by flow cytometry ( n = 6). (C) Gating strategy for identifying F4/80 + CD206 + macrophages, and statistical analyses are shown ( n = 6). (D) Immunofluorescence imaging of colon sections depicting F4/80 + CD206 + cells (green: F4/80, red: CD206, and blue: DAPI) in MSCs‐treated IBD mice, and statistical analyses were shown ( n = 6). (E, F) RNA sequencing analysis identified differential gene expression in MSCs treated with PBS versus NANP, presented as a volcano plot (E) and Gene Ontology enrichment analysis (F) of significantly regulated genes. (G) Heatmap displaying the differential expression of genes involved in regulating cell migration, comparing PBS and NANP treatment. (H) Heatmap view of differential expression gene involved in negative regulation of apoptosis between MSCs and NANP‐treated MSCs. (I) The combination of 25 µM NANP with IT did not enhance anti‐inflammatory cytokine expression compared to IT alone in MSCs ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NANP‐primed MSCs reprogram colitic immunity by restraining inflammatory trafficking. (A) Proportion of CD45 + immune cells in the colon tissues of IBD mice, 6 days post‐MSCs therapy ( n = 6). (B) Distribution of major colonic immune cell subsets, quantified by flow cytometry ( n = 6). (C) Gating strategy for identifying F4/80 + CD206 + macrophages, and statistical analyses are shown ( n = 6). (D) Immunofluorescence imaging of colon sections depicting F4/80 + CD206 + cells (green: F4/80, red: CD206, and blue: DAPI) in MSCs‐treated IBD mice, and statistical analyses were shown ( n = 6). (E, F) RNA sequencing analysis identified differential gene expression in MSCs treated with PBS versus NANP, presented as a volcano plot (E) and Gene Ontology enrichment analysis (F) of significantly regulated genes. (G) Heatmap displaying the differential expression of genes involved in regulating cell migration, comparing PBS and NANP treatment. (H) Heatmap view of differential expression gene involved in negative regulation of apoptosis between MSCs and NANP‐treated MSCs. (I) The combination of 25 µM NANP with IT did not enhance anti‐inflammatory cytokine expression compared to IT alone in MSCs ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: OT‐I cells were isolated from OT‐I transgenic mouse spleens using the Mouse CD8 + T Cell Isolation Kit (CS103‐01, Vazyme) and labeled with eFluor 670 dye (65‐0840‐85, eBioscience).

    Techniques: Immune Cell, Flow Cytometry, Immunofluorescence, Imaging, RNA Sequencing, Analysis, Gene Expression, Quantitative Proteomics, Migration, Expressing, RNA Expression